Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Topical administration of a TxA2 receptor antagonist, seratrodast , at 10−7 M and 10−6 M, significantly attenuated the constriction of large and small arterioles (at 60 min, −9% and −13% constriction for 10−7 M, and −6% and −7% for 10−6 M).”